Beam Therapeutics Inc. (BEAM) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $10.5M. Most recent filing: July 29, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 29, 2026 filed July 27, 2026 | Simon Amy Chief Medical Officer | −$429,037 | 16,667 | −16% | Yes | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Simon Amy Chief Medical Officer | −$12,954 | 373 | −0% | Yes | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | Evans John M. CEO | — | 0 | 0% | Yes | |
|
|
||||||
| June 29, 2026 filed June 25, 2026 | FMR LLC 10% Owner | −$10,039,492 | 284,860 | −25% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Ciaramella Giuseppe President | $34,228 | 71,010 | +166% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free